The digital health sector saw $919 million in funding during the period, compared to $2.73 billion in the second quarter of 2017. The number of funding deals in the sector also dropped 33 percent, from 116 deals in the second quarter of 2017 to 78 deals in the third quarter.
Only one company boasted a “mega-round” of more than $100 million in funding. The startup, personal genomics and biotechnology company 23andMe, reported it raised $250 million. Karius reported the second-largest funding round at $50 million.
Click here to view the full report.
More articles on health IT:
ONC rolls out challenge for secure API servers
HIMSS issues 6-point ‘call to action’ for interoperability
Intermountain launches 3-year genomics study into breast cancer
